Cross-linking of MHC class I molecules on human NK cells inhibits NK cell function, segregates MHC I from the NK cell synapse, and induces intracellular phosphotyrosines

被引:17
|
作者
Rubio, G
Férez, X
Sánchez-Campillo, M
Gálvez, J
Marti, S
Verdú, R
Hernández-Caselles, T
García-Peñarrubia, P
机构
[1] Sch Med, Dept Biochem & Mol Biol & Immunol B, E-30100 Murcia, Spain
[2] Miguel Hernandez Univ, Div Immunol, Alacant, Spain
[3] Fac Sci, Chem Phys Lab, Murcia, Spain
关键词
rafts colocalization; cytoxicity; E : T conjugation;
D O I
10.1189/jlb.1103597
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Engagement of major histocompatibility complex (MHC) class I molecules on immune cells, where they are usually highly expressed, induces signal transduction events of unclear significance. We show here that antibody-mediated cross-linking of MHC-I molecules on human natural killer (NK) cells inhibits their cytotoxic activity against tumor target cells. Inhibition by anti-MHC class I monoclonal antibody exhibits molecular specificity and is an isotype and Fc-independent process. Physical hindrance of specific molecular recognition, induction of apoptosis, or reciprocal NK cell killing, which could be induced by cross-linking of MHC I molecules, has also been ruled out as putative mechanisms of inhibition. Confocal microscopy analysis revealed that MHC class I molecules on the surface of NK cells colocalize constitutively with GM1, a marker of lipid rafts. Crosslinking of MHC class I resulted in the asymmetric redistribution of GM1-enriched raft domains, which are concentrated to the immunological synapse, and MHC I molecules, which segregate to the opposite pole. Also, the cross-linking of MHC I on NK cells induced intracellular tyrosine phosphorylations. These results suggest that MHC I molecules on NK cells could transmit inhibitory signals upon engagement with putative ligands expressed on the surface of those cells that need to be protected from natural cytotoxicity.
引用
收藏
页码:116 / 124
页数:9
相关论文
共 50 条
  • [21] UPREGULATION OF CLASS I MHC ON NEUROBLASTOMA CELLS BY NK CELL EXPOSURE FOR ENHANCED CTL REACTIVITY
    Spel, L.
    van der Steen, D.
    Blokland, N.
    van Noesel, M.
    Heemskerk, M.
    Boelens, J. J.
    Boes, M.
    Nierkens, S.
    CYTOTHERAPY, 2015, 17 (06) : S19 - S19
  • [22] Retuning of mature NK cells after change of MHC class I (MHC-I) environment
    Wagner, A. K.
    Tallerico, R.
    Brauner, H.
    Carbone, E.
    Hoglund, P.
    Johansson, M. H.
    Karre, K.
    IMMUNOLOGY, 2012, 137 : 243 - 244
  • [23] NK cells can recognize different forms of class I MHC
    Su, RC
    Kung, SKP
    Gariépy, J
    Barber, BH
    Miller, RG
    JOURNAL OF IMMUNOLOGY, 1998, 161 (02): : 755 - 766
  • [24] Positive and negative MHC class I recognition by rat NK cells
    Rolstad, B
    Vaage, JT
    Naper, C
    Lambracht, D
    Wonigeit, K
    Joly, E
    Butcher, GW
    IMMUNOLOGICAL REVIEWS, 1997, 155 : 91 - 104
  • [25] Ontogeny of Xenopus NK cells in the absence of MHC class I antigens
    Horton, TL
    Stewart, R
    Cohen, N
    Rau, L
    Ritchie, P
    Watson, MD
    Robert, J
    Horton, JD
    DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2003, 27 (08): : 715 - 726
  • [26] NK cell MHC class I specific receptors (KIR): from biology to clinical intervention
    Thielens, Ariane
    Vivier, Eric
    Romagne, Francois
    CURRENT OPINION IN IMMUNOLOGY, 2012, 24 (02) : 239 - 245
  • [27] ACTIVATION OF HUMAN T-CELL CLONES AND JURKAT CELLS BY CROSS-LINKING CLASS-I MHC MOLECULES
    GEPPERT, TD
    WACHOLTZ, MC
    PATEL, SS
    LIGHTFOOT, E
    LIPSKY, PE
    JOURNAL OF IMMUNOLOGY, 1989, 142 (11): : 3763 - 3772
  • [28] MHC CLASS I EXPRESSION ON HUMAN TUMOR-CELLS AND THEIR SUSCEPTIBILITY TO NK LYSIS
    PENA, J
    SOLANA, R
    ALONSO, MC
    SANTAMARIA, M
    SERRANO, R
    RAMIREZ, R
    CARRACEDO, J
    JOURNAL OF IMMUNOGENETICS, 1989, 16 (4-5): : 407 - 412
  • [29] Editorial: Comparative Genetics of NK Cell Receptor Families in Relation to MHC Class I Ligands and Their Function
    Walter, Lutz
    Bontrop, Ronald
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [30] Allelic variation of the MHC class I-specific NK cell receptor.
    Mehta, IK
    Yokoyama, WM
    FASEB JOURNAL, 1996, 10 (06): : 1080 - 1080